From Dismissal to Validation: How Long-Term Lyme Is Finally Being Taken Seriously

October 20, 2025

Overview

Chronic Lyme Disease is finally being recognized within the scientific community. Studies from MIT, NIH, and Johns Hopkins confirm that Post-Treatment Lyme Disease Syndrome (PTLDS) results in persistent, measurable symptoms that merit serious clinical attention.

Having lingering symptoms of Lyme Disease is hard — and when there’s a history of doubting your diagnosis, it’s even more frustrating.

So when MIT researchers recently announced they were studying Post-Treatment Lyme Disease Syndrome (PTLDS), many sufferers felt a palpable sense of relief.

As the Wall Street Journal reported: “When Gretchen Dunoyer heard that the Massachusetts Institute of Technology was recruiting people with lingering Lyme disease symptoms for a study, she burst into tears.

Dunoyer, 63, had endured near-constant fatigue and vertigo for years after an odd, flulike illness in the summer of 2002. She went from doctor to doctor in search of answers. Many told her she was depressed, but she had a gut feeling something else was wrong.”

“Living with this can be relentlessly debilitating, both mentally and physically.” — Justin Timberlake

Adding to the growing sense of validation was celebrity Justin Timberlake’s recent revelation that he is “living with Lyme Disease.” In an Instagram post, he said what many patients already felt: “If you’ve experienced this disease or know someone who has, then you’re aware: living with this can be relentlessly debilitating, both mentally and physically.”

His personal testimony echoes in the numbers: with an estimated 476,000 Lyme Disease diagnoses annually in the U.S. as many as 95,000 people could face lingering symptoms each year.

So it’s important that scientific institutions are beginning to validate what patients have long known: chronic Lyme symptoms are real.

What Changed About Lyme?

Nothing changed about Lyme Disease or its multi-faceted impact – but it seems the recent pandemic opened some eyes.

What emerged in the aftermath of COVID-19 was a widespread realization that infections can cause long-lasting symptoms in some people. Suddenly and repeatedly, there was evidence of fatigue, pain, and brain fog exhibited by some patients long after they had been infected with COVID-19.

“People had a real-life illustration of how an infection triggers a syndrome. That helped a lot with acceptance.” — Dr. John Aucott, Johns Hopkins

“People had a real-life illustration of how an infection triggers a syndrome. That helped a lot with acceptance.” – Dr. John Aucott (Johns Hopkins)

And – some medical professionals started to wonder – if this trigger was true for Long-COVID, could that same principle apply to Long-Term Lyme?

Doctors and patients wanted to find out – and now the funding followed.

Science Starts to Catch Up

As scientists and doctors looked for answers, the U.S. saw a wave of major studies involving Lyme emerge in the past five years:

2022: Johns Hopkins announced the results of the largest peer-reviewed prospective controlled study in the US to focus specifically on the longer-term outcomes of early diagnosed and promptly treated Lyme disease patients.
- “In this study, 234 patients with early well documented Lyme disease were compared to healthy controls without a history of Lyme disease. When examined 6-12 months after initial antibiotic treatment, 14% of the Lyme disease patients continued to have persistent symptoms (including fatigue, pain, and cognitive symptoms) that impacted quality of life, which was significantly higher than the 4% of the control population exhibiting persistent symptoms.”
2023: The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) announced $3.2 million in funding for five research projects to better understand PTLDS.
2024: The MIT MAESTRO Study began recruiting PTLDS, acute Lyme, and Long-Covid patients to study systemic and mucosal immune responses.
2025: Northwestern University scientists announced a theory as to why PTLDS may occur in some patients and not others: “The body may be responding to remnants of the Borrelia burgdorferi (the bacteria that causes Lyme) cell wall, which breaks down during treatment yet lingers in the liver.”

Yet, while validation feels good and offers hope, there is still much work to be done in the area of Lyme Disease research and treatment.

The Ongoing Challenges

Despite the number of studies now involving the symptoms of Lyme Disease, major challenges remain for both patients and clinicians.

Currently there is:

Lack of a diagnostic test for PTLDS
Lack of clinically-proven treatment beyond symptom management
Ongoing debate around terminology: patients tend to call it “chronic Lyme” while large healthcare organizations often refer to it as PTLDS

In addition to these challenges, there are more as the search for answers continues. Scientific review in 2024 suggests multiple plausible mechanisms for PTLDS, including autoimmune reaction, immune dysfunction, residual infection, and persistent inflammation.

Living with Long-Term Lyme

“For years, patients were dismissed or left without answers – but that reality is changing.”

Living with long-term Lyme can feel exhausting and isolating. For years, patients were dismissed or left without answers – but that reality is changing as science begins to study PTLDS with the seriousness it deserves.

And there’s more good news: while research continues, patients don’t have to wait to take steps. At NutraMedix, we care deeply about your wellness journey and we’re here to support you with microbial balance, gentle detox, immune balance, stress reduction, and more – so you can take control of your health.

“With long-term Lyme now being taken seriously, there is more hope than ever for a return to health.”

We believe every patient deserves to be heard, validated, and supported. That’s why we share knowledge, provide natural options, and keep your well-being at the center of everything we do. With long-term Lyme now being taken seriously, there is more hope than ever for a return to health.

SOURCES

Back to blog